Interferon Beta (IFN-b)
Source: PBL Biomedical Laboratories
Interferon beta, also known as fibroblast interferon, is a type I interferon that has been well characterized
Interferon beta, also known as fibroblast interferon, is a type I interferon that has been well characterized, but is not utilized as widely as IFN-a in research or in the clinic. While fibroblasts are the predominant cellular producers of interferon beta, most PBL IFN-b products are recombinant proteins grown up in E. coli. IFN-b has been approved in the U.S. for the treatment of relapsing forms of multiple sclerosis. Worldwide, other indications have been approved, such as cervical intraepithelial neoplasia.
PBL Biomedical Laboratories, 100 Jersey Avenue, Building D, New Brunswick, NJ 08901. Tel: 732-828-8881; Fax: 732-828-3736.
This website uses cookies to ensure you get the best experience on our website. Learn more